Guardian Pharmacy Services, Inc. (GRDN)
NYSE: GRDN · Real-Time Price · USD
40.81
+1.28 (3.24%)
At close: Aug 3, 2026, 4:00 PM EDT
40.81
0.00 (0.00%)
After-hours: Aug 3, 2026, 4:10 PM EDT

GRDN Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,4561,4491,2281,046908.91792.07
Revenue Growth
13.54%17.93%17.42%15.10%14.75%7.63%
Cost of Revenue
1,1511,156984.04837.88723.04630.81
Gross Profit
304.68292.72244.37208.31185.87161.27
Selling, General & Admin
227.31220.02307.29167.36133.88118.09
Other Operating Expenses
-----13.03
Total Operating Expenses
227.31220.02307.29167.36133.88131.12
Operating Income
12.5872.7-62.9240.9551.9930.15
Interest Expense
-0.33-0.67-3.28-2.86-1.93-1.64
Other Non-Operating Income (Expense)
0.621.39-0.28-0.37-0.4-0.19
Total Non-Operating Income (Expense)
0.280.72-3.56-3.23-2.33-1.82
Pretax Income
12.5973.42-66.4837.7249.6628.33
Provision for Income Taxes
25.3824.474.56---
Net Income
8.8348.96-71.0337.7249.6628.33
Minority Interest in Earnings
0.16-0.2639.0137.72-14.24-12.01
Net Income to Common
9.0349.22-110.05035.4216.31
Net Income Growth
121.43%---117.12%-18.20%
Shares Outstanding (Basic)
636262000
Shares Outstanding (Diluted)
636362000
Shares Change
0.32%2.08%62005711.00%---
EPS (Basic)
0.850.79-1.77-354210.00163140.00
EPS (Diluted)
0.830.78-1.77-354210.00163140.00
EPS Growth
1188.08%---117.12%-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
70.0180.7141.5956.2631.7549.22
Free Cash Flow Growth
44.72%94.05%-26.08%77.20%-35.48%11.17%
Free Cash Flow Per Share
1.101.280.67562630.00317520.00492160.00
Gross Margin
20.93%20.21%19.89%19.91%20.45%20.36%
Operating Margin
0.86%5.02%-5.12%3.91%5.72%3.81%
Profit Margin
0.61%3.38%-5.78%3.61%5.46%3.58%
FCF Margin
4.81%5.57%3.39%5.38%3.49%6.21%
EBITDA
29.8895.04-43.1559.1868.5546.68
EBITDA Margin
2.05%6.56%-3.51%5.66%7.54%5.89%
EBIT
12.5872.7-62.9240.9551.9930.15
EBIT Margin
0.86%5.02%-5.12%3.91%5.72%3.81%
Effective Tax Rate
201.64%33.32%-6.85%0.00%0.00%0.00%
SEC Filings: 10-K · 10-Q